Two differing presentations of periocular dermatitis as a side effect of dupilumab for atopic dermatitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Two differing presentations of periocular dermatitis as a side effect of dupilumab for atopic dermatitis

Published:2019-01-10 Issue:5 Volume:38 Page:390-394
ISSN:0167-6830
Container-title:Orbit
language:en
Short-container-title:Orbit

Author:

Yamane Maya L. M.¹^ORCID,Belsito Donald V.²,Glass Lora R. Dagi³

Affiliation:

1. Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA

2. Department of Dermatology, Columbia University Irving Medical Center, New York, NY, USA

3. Edward S. Harkness Eye Institute, Columbia University Irving Medical Center, New York, NY, USA

Funder

Research to Prevent Blindness

Publisher

Informa UK Limited

Subject

Ophthalmology

Link

https://www.tandfonline.com/doi/pdf/10.1080/01676830.2018.1553190

Reference13 articles.

1. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

2. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

3. Profile of dupilumab and its potential in the treatment of inadequately controlled moderate-to-severe atopic dermatitis

4. Conjunctivitis occurring in atopic dermatitis patients treated with dupilumab–clinical characteristics and treatment

5. Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review of Dupilumab-Induced Adverse Events to Dermatologists and the Potential Pathogenesis in the Treatment of Atopic Dermatitis;Dermatitis®;2024-02-01

2. Management of Facial Erythema on Dupilumab Treatment;Clinical Cases in Dermatology;2024

3. Ocular Surface Adverse Events are not Associated with Dupilumab use in Nasal Polyp Treatment;The Laryngoscope;2023-12

4. Emerging nanotechnology backed formulations for the management of atopic dermatitis;Therapeutic Delivery;2023-09

5. Dupilumab induced ocular surface disease: A prospective case series;European Journal of Ophthalmology;2023-08-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3